Vitiligo

Vitiligo represents a selective destruction of the melanocytes. It is a relatively common, probably autoimmune disorder that affects people of all backgrounds and both genders. No particular group seems to be preferentially affected. Half of vitiligo patients have an onset before the age of 18 years...

Full description

Saved in:
Bibliographic Details
Published inActa dermatovenerologica Alpina, Panonica, et Adriatica Vol. 14; no. 4; pp. 137 - 142
Main Authors Huggins, R H, Schwartz, R A, Janniger, C Krysicka
Format Journal Article
LanguageEnglish
Published Slovenia 01.12.2005
Subjects
Humans
Vitiligo - diagnosis
Vitiligo - etiology
Vitiligo - genetics
Vitiligo - therapy
Online AccessGet full text

Cover

More Information
Summary:Vitiligo represents a selective destruction of the melanocytes. It is a relatively common, probably autoimmune disorder that affects people of all backgrounds and both genders. No particular group seems to be preferentially affected. Half of vitiligo patients have an onset before the age of 18 years. In regions where leprosy is endemic, individuals with vitiligo are often stigmatized due to similarities in appearance between the two diseases. We will review this important subject, emphasizing the latest therapeutic advances.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1318-4458